Prognostic Factors in Merkel Cell Carcinoma: A Retrospective Single-Center Study in 90 Patients
Authors:
- Marco RastrelliMRMarco Rastrelli
- Beatrice FerrazziBFBeatrice Ferrazzi
- Francesco CavallinFCFrancesco Cavallin
- Vanna Chiarion SileniVSVanna Chiarion Sileni
- Jacopo PigozzoJPJacopo Pigozzo
- Alessio FabozziAFAlessio Fabozzi
- Saveria TropeaSTSaveria Tropea
- Antonella VecchiatoAVAntonella Vecchiato
- Alessandra CostaACAlessandra Costa
- Alessandro ParisiAPAlessandro Parisi
- Carlo Riccardo RossiCRCarlo Riccardo Rossi
- Paolo Del FiorePFPaolo Del Fiore
Open Access
Abstract
Merkel Cell Carcinoma (MCC) is a rare but highly aggressive neuroendocrine neoplasm of the skin. This study aimed at describing characteristics, treatment, and prognosis of a series of consecutive cases of MCC patients, in order to contribute to the investigation of this rare malignancy and provide better patient care. This is a retrospective cohort study including all 90 patients diagnosed and/or treated for MCC between 1991 and 2018 at the Veneto Institute of Oncology in Padua (Italy). Patient and tumor characteristics, treatment, and immunohistochemical data were extracted from a prospectively collected local database. There were 68 primary (76%) and 22 non-primary (15 occult primary, three metastatic, four recurrence) tumors (24%). CK20 expression was associated with reduced overall (HR 2.92, 95% CI 1.04–8.16) and disease-specific (HR 4.62, 95% CI 1.31–16.28) survival. Immunomodulatory regimens for treatment of other comorbidities were associated with reduced disease-specific ((HR 2.15, 95% CI 1.06–4.36) and recurrence-free (HR 3.08, 95% CI 1.44–6.57) survival. Iatrogenic immunomodulation resulted as the main factor associated with impaired prognosis. Lack of CK20 expression was associated with better survival.Keywords
This publication has 32 references indexed in Scilit:
- Sentinel lymph node status in Merkel cell carcinoma of the head and neck: Not a predictor of survivalHead & Neck, 2014
- Systemic Immune Suppression Predicts Diminished Merkel Cell Carcinoma–Specific Survival Independent of StageJournal of Investigative Dermatology, 2013
- Radiotherapy is associated with significant improvement in local and regional control in Merkel cell carcinomaRadiation Oncology, 2012
- Merkel cell carcinoma: The prognostic implications of an occult primary in stage IIIB (nodal) diseaseJournal of the American Academy of Dermatology, 2012
- Keratins in health and cancer: more than mere epithelial cell markersOncogene, 2010
- Clonal Integration of a Polyomavirus in Human Merkel Cell CarcinomaScience, 2008
- Merkel cell carcinoma and HIV infectionThe Lancet, 2002
- MERKEL'S CELL CARCINOMA IN ORGAN RECIPIENTSTransplantation, 1999
- Neural cell adhesion molecule immunoreactivity in Merkel cells and Merkel cell tumoursVirchows Archiv, 1995
- Trabecular Carcinoma of the SkinArchives of Dermatology, 1972